中成药在中国用了很多年,到现在几乎是用乱了。利益释然。
去年欧盟几乎把中成药判了死刑。申报药需要15年销售资料。
西方一旦把那些传统的中成药定义为药,意义非凡。
去年欧盟几乎把中成药判了死刑。申报药需要15年销售资料。
西方一旦把那些传统的中成药定义为药,意义非凡。
Drug name | Manufacturer | Active ingredients (if known) | TCM formula | Diseases to treat | Status |
---|---|---|---|---|---|
Danshen dripping pill | Tasly Pharmaceutical | Danshensu, protocatechuic aldehyde, salvianolic acid B | Salvia miltiorrhiza, Radix notoginseng, Borneol | Cardiovascular disease (especially chronic angina) | FDA phase II clinical trials |
Kanglaite injection (KLT) | Zhejiang Kanglaite Group | Unknown | Coix seed oil (with soybean phospholipids and glycerol as excipients) | Cancer | FDA phase II/III clinical trials |
Xuezhikang capsule | Beijing Peking University WBL Biotech Co. | Various natural statins, unsaturated fatty acid, ergosterol, alkaloids | 100% Red yeast rice (Hong Qu), obtained through fermentation of with Monascus strains. | Coronary heart disease caused by hyperlipidaemia and atherosclerosis. | FDA phase II clinical trials |
Fuzheng Huayu capsule | Shanghai University of TCM | Salvianoic acid B, Adenosin | Salvia miltiorrhiza, peach seed, pine pollen, Gynostemma pentaphylla, Schisandra chinensis | Liver fibrosis | FDA Phase II clinical trials |
Nongsuo Danggui Pill | Lanzhou Foci Pharmaceutical | Angelica root | Thrombosis, blood lipid levels and pain | Applying for registration in EU |
Keine Kommentare:
Kommentar veröffentlichen